ISB News

Sid Venkatesh Publishes Co-First Authored Paper in Science

Dr. Sid Venkatesh

ISB Assistant Professor Sid Venkatesh and his team. (Scott Eklund/Red Box Pictures)

ISB Assistant Professor Dr. Sid Venkatesh is the co-first author of a paper in the journal Science.

Following his 2019 work, where he co-led the development of a new class of nutritional interventions, microbiota-directed complementary foods (MDCFs), Venkatesh and Dr. Jiye Cheng (co-first author on the recent paper) identified a novel gut microbial enzyme that impacts satiety-related signaling pathways in undernourished children treated with MDCFs. 

Venkatesh made the discovery as a postdoctoral research associate in Dr. Jeffrey I. Gordon’s laboratory at Washington University in St. Louis. He joined ISB’s faculty in September 2023 and runs the Venkatesh Lab, where he and his research group develop experimental tools and approaches to explore host-microbiome and host-pathogen interactions.

He is also an Affiliate Assistant Professor in the Department of Microbiology at the University of Washington and is an active member of UW’s Microbial Interactions and Microbiome Center (mim_c) community.

  • Read the Science paper here.
  • Read UW mim_c’s interesting and informative news story here.
  • Read WashU’s press release here.

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.